DHR
68
2
CMI
75
4
AMG
82
5
CI
52
4
AMGN
38
4
CHD
35
-5
CME
52
7
APD
50
5
AES
54
7
BWA
55
2
EXR
26
2
ALLE
46
2
DHI
37
-3
AEE
55
4
CF
41
-7
BF.B
39
-3
C
84
2
CL
62
4
AA
82
5
ALL
61
5
DHR
68
2
CMI
75
4
AMG
82
5
CI
52
4
AMGN
38
4
CHD
35
-5
CME
52
7
APD
50
5
AES
54
7
BWA
55
2
EXR
26
2
ALLE
46
2
DHI
37
-3
AEE
55
4
CF
41
-7
BF.B
39
-3
C
84
2
CL
62
4
AA
82
5
ALL
61
5
Financhill
Back

Calamos Convertible Equity Alternative ETF Vs. Monopar Therapeutics, Inc. Industry Stock Comparison

Buy
69

CVRT
Calamos Convertible Equity Alternative ETF

Last Price:
$39.07
Seasonality Move:
6.28%
Sell
41

MNPR
Monopar Therapeutics, Inc.

Last Price:
$70.95
Seasonality Move:
25.93%
Buy
69
Calamos Convertible Equity Alternative ETF (CVRT) is a Buy

Is Calamos Convertible Equity Alternative ETF a Buy, Sell or Hold?

  • The current Calamos Convertible Equity Alternative ETF [CVRT] share price is $39.02. The Score for CVRT is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
  • CVRT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
41
Monopar Therapeutics, Inc. (MNPR) is a Sell

Is Monopar Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Monopar Therapeutics, Inc. [MNPR] share price is $70.92. The Score for MNPR is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • MNPR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CVRT Stock Price Chart

What is Calamos Convertible Equity Alternative ETF's stock price today?

  • The Calamos Convertible Equity Alternative ETF share price today is $39.02
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CVRT is experiencing slight buying pressure.

MNPR Stock Price Chart

What is Monopar Therapeutics, Inc.'s stock price today?

  • The Monopar Therapeutics, Inc. share price today is $70.92
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing slight buying pressure.

CVRT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.22 Buy
Relative Strength Index (14 RSI): 58.95 Buy
Chaikin Money Flow: 1913 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (37.02 - 38.74) Buy
Bollinger Bands (100): (34.55 - 38.27) Buy

MNPR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.54 Sell
Relative Strength Index (14 RSI): 41.3 Sell
Chaikin Money Flow: 7856 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (71.72 - 85.64) Sell
Bollinger Bands (100): (46.03 - 89.35) Buy

CVRT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 38.28 Buy
20-day SMA: 38.23 Buy
50-day SMA: 37.9 Buy
200-day SMA: 33.37 Buy
8-day EMA: 38.36 Buy
20-day EMA: 38.17 Buy
50-day EMA: 37.63 Buy
200-day EMA: 34.45 Buy

MNPR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 71.44 Sell
20-day SMA: 77.62 Sell
50-day SMA: 81.13 Sell
200-day SMA: 52.54 Buy
8-day EMA: 71.33 Sell
20-day EMA: 75.43 Sell
50-day EMA: 76.56 Sell
200-day EMA: 56.82 Buy

Calamos Convertible Equity Alternative ETF Earnings Growth & CVRT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Monopar Therapeutics, Inc. Earnings Growth & MNPR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $1.78 per share.

Calamos Convertible Equity Alternative ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Monopar Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):